FDA Inspection 1161837 - Xellia Pharmaceuticals USA LLC - February 07, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Xellia Pharmaceuticals USA LLC, with an inspection on February 7, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Xellia Pharmaceuticals USA LLC
Inspection Date: February 7, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · d429f017-a9d2-407b-a75e-05a5eb33faa5

Violation Codes1

21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.